The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycle (Q70583860)
scientific article published on 01 January 1984
Language:
(P31) (Q13442814)
(P50) (Q53067237)
(Q126720724)
(P304) 91-94
(P433) 2
(P478) 13
(P577) Sunday, January 1, 1984
(P921) (Q974135)
(Q461809)
(P1433) (Q326137)
(P1476) "The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycle" (language: en)
(P2093) M L Slevin
R C Woollard
M J Barnett
P F Wrigley
P Turner
(P2860) (Q66876992)
(Q68552830)
(Q72725584)
(Q71245588)
(Q51657521)
(Q54451334)
(Q74786929)
(Q72415984)
(Q66919758)
(Q43982160)
(Q70569950)
(Q66992156)
(Q66904658)
(Q71236275)
(Q72063971)
(Q44147246)
(Q38579498)
(Q39716312)
other details
description scientific article published on 01 January 1984

External Links